Treatment of murine cryptococcal meningitis with an SCH 39304-amphotericin B combination
Open Access
- 1 September 1991
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 35 (9), 1721-1725
- https://doi.org/10.1128/aac.35.9.1721
Abstract
Cryptococcal meningitis was induced in BALB/c mice by intracerebral infection with Cryptococcus neoformans. Drug therapy was initiated 1 day later, with mice receiving amphotericin B (AMB), SCH 39304, combination therapy, or no drug therapy (controls). Most, but not all, combinations showed additive benefits, significantly prolonging survival and reducing organism counts in tissues compared with those in controls and groups which received the drugs independently. Optimum protection was obtained when a single dose of 10 mg of AMB per kg of body weight was combined with a fairly narrow SCH 39304 dose range. AMB antagonism did not occur with any regimen tested. AMB-azole combinations may be reasonable alternatives for patients who fail standard cryptococcosis therapeutic regimens.Keywords
This publication has 27 references indexed in Scilit:
- Infections associated with hickman catheters in patients with acquired immunodeficiency syndromeAmerican Journal Of Medicine, 1989
- Life‐Threatening Opportunistic Fungal Infection in Patients with the Acquired Immunodeficiency SyndromeAnnals of the New York Academy of Sciences, 1988
- Liposomes as Carriers of Antifungal DrugsAnnals of the New York Academy of Sciences, 1988
- Controversial Areas in Antifungal Chemotherapy: Short-Course and Combination Therapy with Amphotericin 8Clinical Infectious Diseases, 1987
- Amphotericin B-Induced Oxidative Damage and Killing of Candida albicansThe Journal of Infectious Diseases, 1986
- The Effect of Ketoconazole on Amphotericin B in a Model of Disseminated AspergillosisThe Journal of Infectious Diseases, 1985
- Discrepancies between in vitro activity of and in vivo response to antimicrobial agentsDiagnostic Microbiology and Infectious Disease, 1983
- Combination Therapy of Experimental Candidiasis, Cryptococcosis and Aspergillosis in MiceChemotherapy, 1982
- Combination Therapy of Experimental Histoplasmosis and Cryptococcosis with Amphotericin Band KetoconazoleClinical Infectious Diseases, 1980
- Strategies in the Treatment of Systemic Fungal InfectionsNew England Journal of Medicine, 1980